Your browser doesn't support javascript.
loading
Lymphoma triage from H&E using AI for improved clinical management.
Tsakiroglou, Anna Maria; Bacon, Chris M; Shingleton, Daniel; Slavin, Gabrielle; Vogiatzis, Prokopios; Byers, Richard; Carey, Christopher; Fergie, Martin.
  • Tsakiroglou AM; Spotlight Pathology Ltd, Manchester, UK.
  • Bacon CM; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Shingleton D; Division of Laboratory Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
  • Slavin G; Department of Cellular Pathology, Manchester University NHS Foundation Trust, Manchester, UK.
  • Vogiatzis P; Cellular Pathology Department, Southend University Hospital, Mid & South Essex NHS Trust, Essex, UK.
  • Byers R; Spotlight Pathology Ltd, Manchester, UK.
  • Carey C; Department of Histopathology, Manchester University NHS Foundation Trust, Manchester, UK.
  • Fergie M; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
J Clin Pathol ; 2023 Nov 09.
Article en En | MEDLINE | ID: mdl-37945334
ABSTRACT

AIMS:

In routine diagnosis of lymphoma, initial non-specialist triage is carried out when the sample is biopsied to determine if referral to specialised haematopathology services is needed. This places a heavy burden on pathology services, causes delays and often results in over-referral of benign cases. We aimed to develop an automated triage system using artificial intelligence (AI) to enable more accurate and rapid referral of cases, thereby addressing these issues.

METHODS:

A retrospective dataset of H&E-stained whole slide images (WSI) of lymph nodes was taken from Newcastle University Hospital (302 cases) and Manchester Royal Infirmary Hospital (339 cases) with approximately equal representation of the 3 most prevalent lymphoma subtypes follicular lymphoma, diffuse large B-cell and classic Hodgkin's lymphoma, as well as reactive controls. A subset (80%) of the data was used for training, a further validation subset (10%) for model selection and a final non-overlapping test subset (10%) for clinical evaluation.

RESULTS:

AI triage achieved multiclass accuracy of 0.828±0.041 and overall accuracy of 0.932±0.024 when discriminating between reactive and malignant cases. Its ability to detect lymphoma was equivalent to that of two haematopathologists (0.925, 0.950) and higher than a non-specialist pathologist (0.75) repeating the same task. To aid explainability, the AI tool also provides uncertainty estimation and attention heatmaps.

CONCLUSIONS:

Automated triage using AI holds great promise in contributing to the accurate and timely diagnosis of lymphoma, ultimately benefiting patient care and outcomes.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article